Tag: immune checkpoint inhibitor
By targeting inhibitory checkpoint molecules, with resultant reinvigoration of antitumor immunity, immune checkpoint inhibitors (ICIs) have opened a new chapter in cancer treatment [1].
27.03.2019
 
Myositis as an adverse event of immune checkpoint blockade for cancer therapy; Myositis as a complication of immune checkpoint blockade
01.07.2018